Status:
COMPLETED
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Central Nervous System Lymphoma
Eligibility:
All Genders
18-120 years
Brief Summary
RATIONALE: Studying the genes expressed in samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to ...
Detailed Description
OBJECTIVES: Primary * To better understand the pathophysiology of gliomas and identify molecular markers that may predict prognosis and progression or that could identify new therapeutic approaches....
Eligibility Criteria
Inclusion
- Inclusion Histologically confirmed glioma of any grade or rare primary brain tumor No urgent situation No known or suspected active infection Must not be deprived of liberty or protected by law Not pregnant or nursing
- Exclusion :
- No concurrent participation in other trials that require a period of exclusion
Exclusion
Key Trial Info
Start Date :
November 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00967200
Start Date
November 1 2003
End Date
November 1 2015
Last Update
November 24 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Montpellier
Montpellier, France, 34295
2
Clinique Gui de Chauliac
Montpellier, France, 34295